CLASS II Device recall · Reported 28 Jan 2026 · FDA Enforcement Report

Leaseir Mhr Xcell recalled by Leaseir Technologies Slu

Leaseir Technologies SLU is recalling Leaseir Mhr Xcell, distributed nationwide in the US. The recall was initiated on 15 Dec 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Code: Device#1: Model: Leaseir MHR Xcell Serial Number: C10016, C10017 UDI-DI: 08437019546076
Quantity recalled2

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1130-2026
FDA event ID
98176
Recalling firm
Leaseir Technologies SLU, Gijon
Classification
Class II
Status
Completed
Recall initiated
15 Dec 2025
FDA classified
16 Jan 2026
Reported
28 Jan 2026
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Foreign Material

Timeline

15 Dec 2025Recall initiated by company
16 Jan 2026Classified by FDA+32 days
28 Jan 2026Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The console label for affected devices is missing the "DANGER" symbol.

Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.

Product as listed by the FDA

Brand Name: LEASEIR Product Name: LEASEIR MHR XCELL Model/Catalog Number: MHR 110-b Software Version: 1.5.0.0 Product Description: The Leaseir MHR Xcell is a surgical laser instrument for use in general and plastic surgery and dermatology, intended for hair removal and treatment of pseudo folliculitis barbae on all skin types (Fitzpatrick I-VI). The process implies the generation of intense light pulses at specific wavelengths. The specific nature of the energies and pulse durations cause the desired effect (in the hair follicles and oxyhemoglobin in the blood) heating them sufficiently and destroying them without unnecessary damage to surrounding tissue. This is achieved by controlled emission of laser radiation to the target tissue. The system consists of a main console and two interchangeable applicators that delivers pulsed light in the range of 800-820nm with a peak in the 810nm in different spot sizes. Two of the applicators emitting radiation at 810 nm wavelength for two areas 13.5¿15 mm¿ and 14.5¿25.5 mm¿. Two different operation modes are available: static mode and dynamic mode, which are differentiated basically by the frequency range defined for each mode (1-4 Hz for static and 10 Hz for dynamic). The principle of operation consists in the photons travel along the axis and reflected again back into the crystal, continuing the chain reaction, while photons travelling in different directions leave the crystal. In one of the two mirrors, a tiny hole allows a small amount of light to leak out and the resulting beam is focused with lenses and is emitted from the laser. The total energy emitted by the Leaseir MHR Xcell is produced by an array of diodes. The laser emission is activated by the hand piece trigger, deliver a continuous pulse pattern while the button is pressed. Component: NO

Where it was distributed

US Nationwide distribution in the states of Austin, Texas.

Nationwide Texas

Questions about this recall

Why was it recalled?

The console label for affected devices is missing the "DANGER" symbol.

Which lots are affected?

Lot Code: Device#1: Model: Leaseir MHR Xcell Serial Number: C10016, C10017 UDI-DI: 08437019546076

Where was it sold?

US Nationwide distribution in the states of Austin, Texas.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other Surgical Instruments recalls

All 3,905